| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 771,475 | 707,525 | 947,789 | 813,883 | | Cost of Revenue | 517,344 | 431,795 | 684,152 | 641,710 | | | Gross Profit | 254,131 | 275,730 | 263,637 | 172,173 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 111,105 | 63,797 | 29,891 | 26,634 | | Non Recurring |
-
|
-
|
-
| (54,762) | | Others | 91,623 | 93,378 | 101,284 | 95,561 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 51,403 | 118,555 | 132,462 | 104,740 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (12,799) | 11,878 | 4,756 | 2,648 | | Earnings Before Interest And Taxes | 108,031 | 96,914 | 101,310 | 81,460 | | Interest Expense | 19,903 | 39,490 | 39,784 | 39,338 | | Income Before Tax | 88,128 | 57,424 | 61,526 | 42,122 | | Income Tax Expense | (69,427) | 33,519 | 35,908 | 25,438 | | Minority Interest |
-
|
-
|
-
| (490) | | | | Net Income From Continuing Ops | 88,128 | 57,424 | 61,526 | 42,122 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 88,128 | 57,424 | 61,526 | 42,122 | | Preferred Stock And Other Adjustments | (490) | (490) | (490) |
-
| | | Net Income Applicable To Common Shares | $87,638 | $56,934 | $61,036 | $42,122 |
|
0.11% Nasdaq 0.00%
Income Statement
